Nevro Acquisition Finalized as Trading Ceases on NYSE
Published on 11/09/2025 at 16:42 | Redaktion boerse-global.de
The independent public trading journey of Nevro has reached its conclusion. Effective April 3, 2025, the company’s shares are no longer listed on the New York Stock Exchange, following its complete acquisition by Globus Medical.
The acquisition process, which was initially announced in February 2025, was finalized this April. The transaction saw Globus Medical disburse approximately $250 million in cash and assume all of Nevro’s outstanding shares. Shareholders received $5.85 for each share they held. The agreement received unanimous approval from the boards of directors of both corporations.
With the deal’s completion, Nevro now operates as a wholly-owned subsidiary of Globus Medical. Trading of Nevro stock was terminated immediately, and Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
